Relationship between serum fibroblast growth factor-23 level and mortality in chronic hemodialysis patients

Serum non-high-density lipoprotein cholesterol (non-HDL-C) levels and cardiovascular mortality in chronic hemodialysis patients

(2012) Yoshihisa Echida et al.   Clinical and Experimental Nephrology

Is 24,25(OH)D level really high in dialysis patients with high FGF23 levels?

(2012) Hulya Taskapan   INTERNATIONAL UROLOGY AND NEPHROLOGY

Serum Fibroblast Growth Factor-23 Levels and Progression of Aortic Arch Calcification in Non-Diabetic Patients on Chronic Hemodialysis

(2011) Noriko Tamei et al.   Journal of Atherosclerosis and Thrombosis

FGF23 induces left ventricular hypertrophy

(2011) Christian Faul et al.   JOURNAL OF CLINICAL INVESTIGATION

FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages

(2011) L. Desjardins et al.   OSTEOPOROSIS INTERNATIONAL

Fibroblast Growth Factor 23 in Chronic Kidney Disease: Bridging the Gap between Bone Mineral Metabolism and Left Ventricular Hypertrophy

(2010) M.E.F. Canziani et al.   BLOOD PURIFICATION

The relationship between circulating fibroblast growth factor 23 and bone metabolism factors in Korean hemodialysis patients

(2010) So-Youn Park et al.   Clinical and Experimental Nephrology

Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients

(2010) A. Kirkpantur et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients

(2010) M. M. Nasrallah et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship?

(2010) H. Olauson et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Fibroblast Growth Factor 23: A Possible Cause of Left Ventricular Hypertrophy in Hemodialysis Patients

(2009) Heng Jung Hsu et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community

(2009) Majd A.I. Mirza et al.   ATHEROSCLEROSIS

Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population

(2009) Majd A.I. Mirza et al.   ATHEROSCLEROSIS

Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease

(2009) Orlando M. Gutiérrez et al.   CIRCULATION

Relationship between circulating FGF23 and total body atherosclerosis in the community

(2009) Majd A. I. Mirza et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients

(2009) G. Jean et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Investigation of Gender Heterogeneity in the Associations of Serum Phosphorus With Incident Coronary Artery Disease and All-Cause Mortality

(2008) S. J. Onufrak et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis

(2008) Fumiko Kojima et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences

(2008) G. Jean et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis

(2008) Orlando M. Gutiérrez et al.   NEW ENGLAND JOURNAL OF MEDICINE